Darren Snellgrove
SVP, Chief Financial Officer · HALOZYME THERAPEUTICS, INC.
Individual
- 2026
- Jul 2, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Darren Snellgrove files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Matthew L. Posard - $2.61M in HALO purchases and sales in the last 12 months
- Cortney Caudill - $1.96M in HALO purchases and sales in the last 12 months
- Bernadette Connaughton - $699K in HALO purchases and sales in the last 12 months
- Mahesh Krishnan - $548K in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Darren Snellgrove?
Darren Snellgrove is a corporate insider, tracked as SVP, Chief Financial Officer of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Darren Snellgrove last file a Form 4?
The only primary Form 4 on record is dated 2 July 2026.